A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Annals of Human Biology

Volumn 38, Issue 2, 2011, Pages 194-202

  Crowe, Francesca L ^a   Key, Timothy J ^a   Allen, Naomi E ^a   Appleby, Paul N ^a   Overvad, Kim ^b,c   Grønbæk, Henning ^d   Tjønneland, Anne ^e   Halkjær, Jytte ^f   Dossus, Laure ^f   Boeing, Heiner ^g   Kröger, Janine ^g   Trichopoulou, Antonia ^h   Zylis, Dimosthenis ^h   Trichopoulos, Dimitrios ^i,j   Boutron Ruault, Marie Christine ^k   De Lauzon Guillain, Blandine ^k   Clavel Chapelon, Françoise ^k   Palli, Domenico ^l   Berrino, Franco ^m   Panico, Salvatore ⁿ   Tumino, Rosario ^o   Sacerdote, Carlotta ^p   Bueno De Mesquita, H Bas ^q,r   Van Gils, Carla H ^r   Peeters, Petra H M ^r,s   Gram, Inger T ^t   Rodŕguez, Laudina ^u   Jakszyn, Paula ^v   Molina Montes, Esther ^w,x   Navarro, Carmen ^x,y   Barricarte, Aurelio ^x,z   Larräaga, Nerea ^x,aa   Khaw, Kay Tee ^ab   Rodwell, Sheila ^ac   Rinaldi, Sabina ^ad   Slimani, Nadia ^ad   Norat, Teresa ^s   Gallo, Valentina ^s   Riboli, Elio ^s   Kaaks, Rudolf ^f   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^k CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^l CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s IMPERIAL COLLEGE LONDON   (United Kingdom)

^t UNIVERSITY OF TROMSØ   (Norway)

^u Health and Health Care Services Council   (Spain)

^v CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^z INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aa Basque Government   (Spain)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

Body height; Body mass index; Insulin like growth factor binding proteins; Insulin like growth factor I; Obesity

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE CLASS; BODY MASS; BODY SIZE; CANCER; CONCENTRATION (COMPOSITION); HEALTH RISK; HEIGHT DETERMINATION; HORMONE; OBESITY; PEPTIDE; PROTEIN; RISK FACTOR; SERUM;

ADULT; AGED; ARTICLE; BLOOD; BODY HEIGHT; BODY MASS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EUROPE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; NUTRITIONAL STATUS; RISK FACTOR;

ADULT; AGED; BODY HEIGHT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASMS; NUTRITIONAL STATUS; RISK FACTORS;

EID: 79551495819     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2010.507221     Document Type: Article

References (50)

1. Albanes D, Winick M. 1988. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 80:772-775.
2. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S, Egevad L, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Grønb?k H, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Kay TK, Tumino R, Berrino F, Mattiello A, Sacerdote C, Palli D, Quirós JR, Ardanaz E, Navarro C, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Travezea C, Trichopoulos D, Jenab M, Ferrari P, Riboli E, Kaaks R. 2007. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16:1121-1127.
3. Baibas N, Bamia C, Vassilopoulou E, Sdrolias J, Trichopoulou A, Trichopoulos D. 2003. Dietary and lifestyle factors in relation to plasma insulin-like growth factor I in a general population sample. Eur J Cancer Prev 12:229-234.
4. Ben-Shlomo Y, Holly J, McCarthy A, Savage P, Davies D, Gunnell D, Davey Smith G. 2003. An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood. Clin Endocrinol (Oxf) 59:366-373.
5. Butler AA, Le Roith D. 2001. Control of growth by the somatropic axis: Growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141-164.
6. Calle EE, Kaaks R. 2004. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591.
7. Clark JM. 2006. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40:S5-S10.
8. Conover CA, Lee PDK. 1990. Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells. J Clin Endocrinol Metab 70:1062-1067.
9. Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault M, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós JR, Agudo A, Sánchez MJ, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PHM, VanGils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R. 2007. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 120: 2656-2664. (Pubitemid 46651288)
10. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L. 2004. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): The Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 13:1444-1451.
11. DeLellis Henderson K, Le Marchand L. 2007. Obesity and insulin-like growth factor-I in African Americans and whites. Cancer Epidemiol Biomarkers Prev 16:1526.
12. Fall CHD, Pndit AN, Law CM, Yajnik CS, Clark PM, Breier B, Osmond C, Shiell AW, Gluckman PD, Barker DJP. 1995. Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child 73:287-293.
13. Faupel-Badger JM, Berrigan D, Ballard-Barbash R, Potischman N. 2009. Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ ethnicity and gender. Ann Epidemiol 19:841-849.
14. Frystyk J. 2004. Free insulin-like growth factors - Measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 14:337-375.
15. Gasser T, Sheehy A, Molinari L, Largo RH. 2001. Growth of early and late maturers. Ann Hum Biol 28:328-336.
16. Goodman-Gruen D, Barrett-Connor E. 1997. Epidemiology of insulinlike growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 145:970-976.
17. Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, Téhard B, Clavel-Chapelon F, Van Gils CH, Van Noord PAH, Peeters PHM, Bueno-De-Mesquita HB, Nagel G, Linseisen J, Lahmann PH, Boeing H, Palli D, Sacerdote C, Panico S, Tumino R, Sieri S, Dorronsoro M, Quirós JR, Navarro CA, Barricarte A, Tormo M, González CA, Overvad K, Johnsen SP, Olsen A, Tjønneland A, Travis R, Allen N, Bingham S, Khaw K, Stattin P, Trichopoulou A, Kalapothaki V, Psaltopoulou T, Casagrande C, Riboli E, Kaaks R. 2006. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes 30:1623-1631.
18. Gunnell D. 2000. Height, insulin-like growth factors and cancer risk. Growth Horm IGF Res 10:39-40.
19. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-De-Mesquita HB, Peeters PHM, Skeie G, Hjartåker A, Rodriguez M, Quirós JR, Berglund G, Janlert U, Khaw KT, Spencer EA, Overvad K, Tjønneland A, Clavel-Chapelon F, Tehard B, Miller AB, Klipstein- Grobusch K, Benetou V, Kiriazi G, Riboli E, Slimani N. 2002. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1147-1162.
20. Heald AH, Sharma R, Anderson SG, Vyas A, Siddals K, Patel J, Bhatnagar D, Prabharkaran D, Rudenski A, Hughes E, Durrington P, Gibson JM, Cruickshank JK. 2005. Dietary intake and the insulin-like growth factor system: Effects of migration in two related populations in India and Britain with markedly different dietary intake. Public Health Nutr 8:620-627.
21. Holmes MD, Pollak MN, Willett WC, Hankinson SE. 2002. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:852-861.
22. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R. 2005. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 14:2881-2998.
23. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjønneland A, Olsen A, Overvad K, Grønb?k H, Clavel-Chapelon F, Boutron-Ruault M, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters PH, Van Gils CH, Bueno-de-Mesquita HB, Ocké MC, Lund E, Mendez MA, Tormo MJ, Barricarte A, Martínez-García C, Dorronsoro M, Quirós JR, Hallmans G, Palmqvist R, Berglund G, Manjer J, KeyT, Allen NE, Bingham S, Khaw K, Cust A, Kaaks R. 2007. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368-376. (Pubitemid 46917707)
24. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34.
25. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K, Müller J, Hall K, Skakkeb?k NE. 1994. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752.
26. Juul A, Fisker S, Scheike T, Hertel T, Müller J, ørskov H, Skakkeb?k NE. 2000. Serum levels of growth hormone binding protein in children with normal and precocious puberty: Relation to age, gender, body composition and gonadal steroids. Clin Endocrinol (Oxf) 52:165-172.
27. Kaaks R, Lukanova A, Kurzer MS. 2002. Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-1543.
28. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson Jr. HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR. 2003. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226. (Pubitemid 37069552)
29. Larnkjaer A, Ingstrup HK, Schack-Nielsen L, Hoppe C, Mølgaard C, Skovgaard IM, Juul A, Michaelsen KF. 2009. Early programming of the IGF-I axis: Negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects. Growth Horm IGF Res 19:82-86.
30. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R. 2004. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: A cross-sectional study in healthy women. Eur J Endocrinol 150:161-171.
31. Lukanova A, Söderberg S, Stattin P, Palmqvist R, Lundin E, Biessy C, Rinaldi S, Riboli E, Hallmans G, Kaaks R. 2002. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGFbinding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Contr 13:509-516.
32. Ong K, Kratzsch J, KiessW, Dunger D. 2002. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 87:1041-1044.
33. Peeters PH, Lukanova A, Allen N, Berrino F, Key T, Dossus L, Rinaldi S, van Gils CH, Bueno-de-Mesquita HB, Boeing H, Schulz M, Chang-Claude J, Linseisen J, Panico S, Sacerdote C, Palli D, Tumino R, Trichopoulou A, Trichopolos D, Bamia C, Larranaga N, Ardanaz E, Pera G, Quirós JR, Martínez- García C, Navarro C, Bingham SA, Khaw KT, Clavel F, Tjonneland A, Olsen A, Overvad K, Tetsche MS, Lund E, Lundin E, Berglund G, Riboli E, Kaaks R. 2007. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14:81-90.
34. Probst-Hensch NM,Wang H, Goh VHH, Seow A, Lee H, Yu MC. 2003. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 12:739-746.
35. Probst-Hensch NM, Yuan J, Stanczyk FZ, Gao Y, Ross RK, Yu MC. 2001. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: Association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 85:1695-1699.
36. Renehan AG, Zwahlen M, Minder C, O?Dwyer ST, Shalet SM, Egger M. 2004. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet 363:1346-1353.
37. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondier̀e UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PHM, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. 2002. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr 5:1113-1124. (Pubitemid 36313608)
38. Rinaldi S, Peeters PHM, Berrino F, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Téhard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Trichopoulou A, Trichopoulos D, Koliva M, Palli D, Panico S, Tumino R, Sacerdote C, Van Gils CH, Van Noord P, Grobbee DE, Bueno-De-Mesquita HB, Gonzalez CA, Agudo A, Chirlaque MD, Barricarte A, Larrañaga N, Quiros JR, Bingham S, Khaw KT, Key T, Allen NE, Lukanova A, Slimani N, Saracci R, Riboli E, Kaaks R. 2006. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593-605. (Pubitemid 43886679)
39. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J. 2006. Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 91:2514-2519.
40. Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ. 2004. Association between insulin-like growth factor-I: Insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Cancer Epidemiol Biomarkers Prev 13:166-170.
41. Scacchi M, Pincelli AI, Cavagnini F. 1999. Growth hormone in obesity. Int J Obes 23:260-271.
42. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. 2007. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer 14:721-732.
43. Schmid C, Schlapfer I, Waldvogel M, Meier PJ, Schwander J, Boni-Schnetzler M, Zapf J, Froesch ER. 1992. Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett 303:205-209.
44. Spencer EA, Appleby PN, DaveyGK, Key TJ. 2002. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5:561-565.
45. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S. 2002. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middleaged Japanese men. Am J Epidemiol 156:344-348.
46. The Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW. 2010. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-542.
47. Trichopoulos D, Lipworth L. 1995. Is cancer causation simpler than we thought, but more intractable? Epidemiology 6:347-349.
48. Walenkamp MJE, Wit JM, Kant SG, Pereira AM, Karperien M, Oostdijk W, Van Duyvenvoorde HA, Losekoot M, Breuning MH, Romijn JA. 2006. Genetic disorders in the growth hormone - Insulin-like growth factor-I axis. Horm Res 66:221-230.
49. Wheatcroft SB, Kearney MT. 2009. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: Implications for metabolic homeostasis. Trends Endocrinol Metab 20:153-162.
50. World Cancer Research Fund/American Institute for Cancer Research. 2007. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington DC: AICR